Need Help? Call 1­-866-­796-­7386
« back to stock screener

  MNTA stock: Momenta Pharmaceuticals, Inc.

Current Rating
Strong Sell

Previous Rating

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$17.30
Market Cap
1.28B
Sector
Health Care
Div. Growth
-
P/E
-
P/B
3.29
P/S
10.94
Dividend %
-
P/CF
15.7
P/FCF
25.1
Op. Cash Flow
51.9K
FCF
0.6
Op. Margin
-106.50%
Net Margin
-55.60%
ROE
-16.20%
ROI
-20.10%
ROA
-11.80%
EPS Growth
40.20%
Current Ratio
6.1
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Pieris Pharmaceuticals Inc (PIRS) $8.59 - - 343.6M Strong Buy
China Pharma Holdings, Inc. (CPHI) $0.42 - - 14.8M Strong Buy
CV Sciences Inc (CVSI) $0.41 - - 33.9M Strong Buy
Encision Inc (ECIA) $0.40 - - 4.7M Strong Buy
Aradigm Corporation (ARDM) $1.32 - - 20.1M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More